Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2050190 | FEBS Letters | 2008 | 7 Pages |
Abstract
The dominant conceptual reductionism in drug discovery has resulted in many promising drug candidates to fail during the last clinical phases, mainly due to a lack of knowledge about the patho-physiological pathways they are acting on. Consequently, to increase the revenues of the drug discovery process, we need to improve our understanding of the molecular mechanisms underlying complex cellular processes and consider each potential drug target in its full biological context. Here, we review several strategies that combine computational and experimental techniques, and suggest a systems pathology approach that will ultimately lead to a better comprehension of the molecular bases of disease.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Roland A. Pache, Andreas Zanzoni, Jordi Naval, José Manuel Mas, Patrick Aloy,